Alcon to Acquire Tear Film Innovations for its iLux Medical Device
Shots:
- Alcon acquires Tear Film in all stock transaction with its iLux device- used for the treatment of Meibomian Gland Dysfunction
- The focus of the acquisition is to strengthen and expand Alcon’s ocular products in the US and Canada- including Tear’s iLux device for dry eye relief
- The iLux Device is an easy-to-use- portable medical device that directly helps in visualizing meibomian gland orifices indicated for used for Meibomian Gland Dysfunction and has also received FDA’s 510 (k) approval
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
